BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28846828)

  • 1. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.
    Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M
    J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.
    De Carlis L; Di Sandro S; Giacomoni A; Mihaylov P; Lauterio A; Mangoni I; Cusumano C; Poli C; Tripepi M; Bencardino K
    Eur J Surg Oncol; 2013 Jul; 39(7):726-33. PubMed ID: 23601983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.
    Tanaka K; Shimada H; Miura M; Fujii Y; Yamaguchi S; Endo I; Sekido H; Togo S; Ike H
    World J Surg; 2004 Mar; 28(3):263-70. PubMed ID: 14961200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.
    Ardito F; Arena V; Vellone M; Grande G; Pennacchia I; Majellaro F; Giovannini I; Vecchio FM; Nuzzo G; Giuliante F
    J Gastrointest Surg; 2014 Nov; 18(11):1987-93. PubMed ID: 25231080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
    Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
    Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
    J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
    Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
    Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.
    Hasegawa Y; Nitta H; Sasaki A; Takahara T; Itabashi H; Katagiri H; Otsuka K; Nishizuka S; Wakabayashi G
    Surgery; 2015 Jun; 157(6):1065-72. PubMed ID: 25791030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
    Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
    Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    Konishi T; Yoshidome H; Shida T; Furukawa K; Takayashiki T; Kuboki S; Takano S; Miyazaki M; Ohtsuka M
    J Surg Oncol; 2021 Sep; 124(4):598-606. PubMed ID: 34061356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Miki K; Kobayashi K; Morita K
    Dig Surg; 2010; 27(4):285-90. PubMed ID: 20689289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
    Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
    Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.